Robert Nelsen, Director at AGIOS PHARMACEUTICALS INC (AGIO), sold 47,859 shares at $49.47 ($2.4M) on 2017-02-28, disclosed to the SEC on 2017-03-01.
Open-market sale of $2.4M AGIO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.47 | 27,622 | $1.4M | 57.4% |
| 2 | $50.18 | 20,237 | $1.0M | 42.6% |
| Total | $49.77 avg | 47,859 | $2.4M | 100% |
| Filing → |
| SANA | BUY | 2024-02-12 | $8.0M | — | Filing → |
| NMRA | BUY | 2023-09-29 | $2.1M | — | Filing → |
| NMRA | BUY | 2023-09-27 | $1.0M | — | Filing → |